BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10820288)

  • 1. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
    Verhoef A; Lamb JR
    J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.
    Tsitoura DC; Holter W; Cerwenka A; Gelder CM; Lamb JR
    J Immunol; 1996 Apr; 156(8):2801-8. PubMed ID: 8609399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells.
    Tsitoura DC; Verhoef A; Gelder CM; O'Hehir RE; Lamb JR
    J Immunol; 1996 Sep; 157(5):2160-5. PubMed ID: 8757342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF-beta in activation and anergy.
    Tsitoura DC; Gelder CM; Kemeny DM; Lamb JR
    Immunology; 1997 Sep; 92(1):10-9. PubMed ID: 9370918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling.
    Faith A; Akdis CA; Akdis M; Joss A; Wymann D; Blaser K
    J Immunol; 1999 Feb; 162(3):1836-42. PubMed ID: 9973449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
    Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
    J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide.
    Matsuoka T; Kohrogi H; Ando M; Nishimura Y; Matsushita S
    J Immunol; 1996 Dec; 157(11):4837-43. PubMed ID: 8943386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function.
    Lamb JR; Higgins JA; Hetzel C; Hayball JD; Lake RA; O'Hehir RE
    Immunology; 1995 Jul; 85(3):447-54. PubMed ID: 7558134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55.
    Ford ML; Evavold BD
    J Immunol; 2003 Aug; 171(3):1247-54. PubMed ID: 12874212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
    Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
    J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of T cell anergy by low numbers of agonist ligands.
    Korb LC; Mirshahidi S; Ramyar K; Sadighi Akha AA; Sadegh-Nasseri S
    J Immunol; 1999 Jun; 162(11):6401-9. PubMed ID: 10352253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD3-induced anergy in cloned human Th0, Th1, and Th2 cells.
    Nguyen DD; Beck L; Spiegelberg HL
    Cell Immunol; 1995 Oct; 165(1):153-7. PubMed ID: 7671320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones.
    Fasler S; Aversa G; de Vries JE; Yssel H
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):521-30. PubMed ID: 9564806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.
    Itoh Y; Germain RN
    J Exp Med; 1997 Aug; 186(5):757-66. PubMed ID: 9271591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones.
    Yssel H; Johnson KE; Schneider PV; Wideman J; Terr A; Kastelein R; De Vries JE
    J Immunol; 1992 Feb; 148(3):738-45. PubMed ID: 1370514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.
    Dubey C; Croft M; Swain SL
    J Immunol; 1996 Oct; 157(8):3280-9. PubMed ID: 8871622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The magnitude of TCR engagement is a critical predictor of T cell anergy or activation.
    Mirshahidi S; Ferris LC; Sadegh-Nasseri S
    J Immunol; 2004 May; 172(9):5346-55. PubMed ID: 15100274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
    Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.